Medtronic's Attain Stability Quad MRI SureScan Left Heart Lead Receives FDA's Approval for Heart Failure
Shots:
- The Attain Stability Quad MRI Surescan left heart lead with quadripolar cardiac resynchronization therapy-defibrillators (CRT-D) & pacemakers (CRT-P) is targeted for precise lead placement and stability and will be available in the US in H1’19
- The Attain Stability Quad lead is a quadripolar lead with a side-helix allowing the physicians to fixate the leads in sizes of veins
- CRT is an implantable device sending leads for the stimulation of heart muscles leading to an improvement in heart pumping efficiency to treat heart failure. Additionally- Medtronic’s portfolio has therapies & diagnostic tools for HF including MR-conditional CRT-Ds and CRT-Ps
Ref: GlobeNewswire | Image: Gizmodo
Click here to read the full press release
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com